Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 3
×
Completed
×
cabozantinib
×
Clear all
Filters
3
NCT04471428
2025-12-22
CONTACT-01
Hoffmann-La Roche
Phase 3
Completed
366 enrolled
24 charts
NCT01908426
2021-05-06
CELESTIAL
Exelixis
Phase 3
Completed
707 enrolled
20 charts
2 FDA
NCT01865747
2021-04-27
METEOR
Exelixis
Phase 3
Completed
658 enrolled
15 charts
NCT01605227
2018-03-14
COMET-1
Exelixis
Phase 3
Completed
1,028 enrolled
18 charts